Selected research
Industry Research
Caspofungin Industry Research Report 2026
Market perspective
The global Caspofungin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Caspofungin market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Caspofungin market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Caspofungin market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Caspofungin include Sun Pharmaceutical Industries Ltd., Sanofi S.A., Merck & Co., Inc., Sundent Pharmaceutical Co. Ltd., Juno Pharmaceuticals (MDA Inc.), Gland Pharma Limited, Fresenius SE & Co. KGaA (Fresenius Kabi), Cipla Inc. and Athenex, Inc. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Caspofungin market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Caspofungin.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Caspofungin Market by Company
Sun Pharmaceutical Industries Ltd.
Sanofi S.A.
Merck & Co., Inc.
Sundent Pharmaceutical Co. Ltd.
Juno Pharmaceuticals (MDA Inc.)
Gland Pharma Limited
Fresenius SE & Co. KGaA (Fresenius Kabi)
Cipla Inc.
Athenex, Inc.
Alvogen Inc.
Caspofungin Segment by Type
Injection Product
Table Product
Others
Caspofungin Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Caspofungin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Caspofungin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Caspofungin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Caspofungin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Caspofungin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Product
- Table Product
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Merck & Co., Inc.
- Sundent Pharmaceutical Co. Ltd.
- Juno Pharmaceuticals (MDA Inc.)
- Gland Pharma Limited
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Cipla Inc.
- Athenex, Inc.
- Alvogen Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Caspofungin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Injection Product
- 2.2.3 Table Product
- 2.2.4 Others
- 2.3 Caspofungin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
3 Caspofungin Breakdown Data by Type
- 3.1 Global Caspofungin Historic Market Size by Type (2021-2026)
- 3.2 Global Caspofungin Forecasted Market Size by Type (2027-2032)
4 Caspofungin Breakdown Data by Application
- 4.1 Global Caspofungin Historic Market Size by Application (2021-2026)
- 4.2 Global Caspofungin Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Caspofungin Market Perspective (2021-2032)
- 5.2 Global Caspofungin Growth Trends by Region
- 5.2.1 Global Caspofungin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Caspofungin Historic Market Size by Region (2021-2026)
- 5.2.3 Caspofungin Forecasted Market Size by Region (2027-2032)
- 5.3 Caspofungin Market Dynamics
- 5.3.1 Caspofungin Industry Trends
- 5.3.2 Caspofungin Market Drivers
- 5.3.3 Caspofungin Market Challenges
- 5.3.4 Caspofungin Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Caspofungin Players by Revenue
- 6.1.1 Global Top Caspofungin Players by Revenue (2021-2026)
- 6.1.2 Global Caspofungin Revenue Market Share by Players (2021-2026)
- 6.2 Global Caspofungin Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Caspofungin Head Office and Area Served
- 6.4 Global Caspofungin Players, Product Type & Application
- 6.5 Global Caspofungin Manufacturers Established Date
- 6.6 Global Caspofungin Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Caspofungin Market Size (2021-2032)
- 7.2 North America Caspofungin Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Caspofungin Market Size by Country (2021-2026)
- 7.4 North America Caspofungin Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Caspofungin Market Size (2021-2032)
- 8.2 Europe Caspofungin Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Caspofungin Market Size by Country (2021-2026)
- 8.4 Europe Caspofungin Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Caspofungin Market Size (2021-2032)
- 9.2 Asia-Pacific Caspofungin Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Caspofungin Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Caspofungin Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Caspofungin Market Size (2021-2032)
- 10.2 South America Caspofungin Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Caspofungin Market Size by Country (2021-2026)
- 10.4 South America Caspofungin Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Caspofungin Market Size (2021-2032)
- 11.2 Middle East & Africa Caspofungin Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Caspofungin Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Caspofungin Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sun Pharmaceutical Industries Ltd.
- 12.1.1 Sun Pharmaceutical Industries Ltd. Company Information
- 12.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 12.1.3 Sun Pharmaceutical Industries Ltd. Revenue in Caspofungin Business (2021-2026)
- 12.1.4 Sun Pharmaceutical Industries Ltd. Caspofungin Product Portfolio
- 12.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 12.2 Sanofi S.A.
- 12.2.1 Sanofi S.A. Company Information
- 12.2.2 Sanofi S.A. Business Overview
- 12.2.3 Sanofi S.A. Revenue in Caspofungin Business (2021-2026)
- 12.2.4 Sanofi S.A. Caspofungin Product Portfolio
- 12.2.5 Sanofi S.A. Recent Developments
- 12.3 Merck & Co., Inc.
- 12.3.1 Merck & Co., Inc. Company Information
- 12.3.2 Merck & Co., Inc. Business Overview
- 12.3.3 Merck & Co., Inc. Revenue in Caspofungin Business (2021-2026)
- 12.3.4 Merck & Co., Inc. Caspofungin Product Portfolio
- 12.3.5 Merck & Co., Inc. Recent Developments
- 12.4 Sundent Pharmaceutical Co. Ltd.
- 12.4.1 Sundent Pharmaceutical Co. Ltd. Company Information
- 12.4.2 Sundent Pharmaceutical Co. Ltd. Business Overview
- 12.4.3 Sundent Pharmaceutical Co. Ltd. Revenue in Caspofungin Business (2021-2026)
- 12.4.4 Sundent Pharmaceutical Co. Ltd. Caspofungin Product Portfolio
- 12.4.5 Sundent Pharmaceutical Co. Ltd. Recent Developments
- 12.5 Juno Pharmaceuticals (MDA Inc.)
- 12.5.1 Juno Pharmaceuticals (MDA Inc.) Company Information
- 12.5.2 Juno Pharmaceuticals (MDA Inc.) Business Overview
- 12.5.3 Juno Pharmaceuticals (MDA Inc.) Revenue in Caspofungin Business (2021-2026)
- 12.5.4 Juno Pharmaceuticals (MDA Inc.) Caspofungin Product Portfolio
- 12.5.5 Juno Pharmaceuticals (MDA Inc.) Recent Developments
- 12.6 Gland Pharma Limited
- 12.6.1 Gland Pharma Limited Company Information
- 12.6.2 Gland Pharma Limited Business Overview
- 12.6.3 Gland Pharma Limited Revenue in Caspofungin Business (2021-2026)
- 12.6.4 Gland Pharma Limited Caspofungin Product Portfolio
- 12.6.5 Gland Pharma Limited Recent Developments
- 12.7 Fresenius SE & Co. KGaA (Fresenius Kabi)
- 12.7.1 Fresenius SE & Co. KGaA (Fresenius Kabi) Company Information
- 12.7.2 Fresenius SE & Co. KGaA (Fresenius Kabi) Business Overview
- 12.7.3 Fresenius SE & Co. KGaA (Fresenius Kabi) Revenue in Caspofungin Business (2021-2026)
- 12.7.4 Fresenius SE & Co. KGaA (Fresenius Kabi) Caspofungin Product Portfolio
- 12.7.5 Fresenius SE & Co. KGaA (Fresenius Kabi) Recent Developments
- 12.8 Cipla Inc.
- 12.8.1 Cipla Inc. Company Information
- 12.8.2 Cipla Inc. Business Overview
- 12.8.3 Cipla Inc. Revenue in Caspofungin Business (2021-2026)
- 12.8.4 Cipla Inc. Caspofungin Product Portfolio
- 12.8.5 Cipla Inc. Recent Developments
- 12.9 Athenex, Inc.
- 12.9.1 Athenex, Inc. Company Information
- 12.9.2 Athenex, Inc. Business Overview
- 12.9.3 Athenex, Inc. Revenue in Caspofungin Business (2021-2026)
- 12.9.4 Athenex, Inc. Caspofungin Product Portfolio
- 12.9.5 Athenex, Inc. Recent Developments
- 12.10 Alvogen Inc.
- 12.10.1 Alvogen Inc. Company Information
- 12.10.2 Alvogen Inc. Business Overview
- 12.10.3 Alvogen Inc. Revenue in Caspofungin Business (2021-2026)
- 12.10.4 Alvogen Inc. Caspofungin Product Portfolio
- 12.10.5 Alvogen Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst